As of 2024-12-12, the Relative Valuation of Ose Immunotherapeutics SA (OSE.PA) is 32.16 EUR. This relative valuation is based on P/E multiples. With the latest stock price at 8.10 EUR, the upside of Ose Immunotherapeutics SA based on Relative Valuation is 297.1%.
The range of the Relative Valuation is 17.35 - 38.51 EUR.
| Range | Selected | |
| Trailing P/E multiples | 16.2x - 18.2x | 17.2x |
| Forward P/E multiples | 8.2x - 18.2x | 13.2x |
| Fair Price | 17.35 - 38.51 | 32.16 |
| Upside | 114.2% - 375.5% | 297.1% |
| Date | P/E |
| 2024-12-10 | 3.83 |
| 2024-12-09 | 3.77 |
| 2024-12-06 | 3.68 |
| 2024-12-05 | 3.54 |
| 2024-12-04 | 3.50 |
| 2024-12-03 | 3.53 |
| 2024-12-02 | 3.46 |
| 2024-11-29 | 4.17 |
| 2024-11-28 | 4.16 |
| 2024-11-27 | 4.23 |
| 2024-11-26 | 4.20 |
| 2024-11-25 | 4.23 |
| 2024-11-22 | 4.20 |
| 2024-11-21 | 4.10 |
| 2024-11-20 | 4.09 |
| 2024-11-19 | 4.29 |
| 2024-11-18 | 4.15 |
| 2024-11-15 | 4.20 |
| 2024-11-14 | 4.37 |
| 2024-11-13 | 4.38 |
| 2024-11-12 | 4.41 |
| 2024-11-11 | 4.59 |
| 2024-11-08 | 4.68 |
| 2024-11-07 | 4.75 |
| 2024-11-06 | 4.69 |
| 2024-11-05 | 4.84 |
| 2024-11-04 | 5.08 |
| 2024-11-01 | 4.84 |
| 2024-10-31 | 4.75 |
| 2024-10-30 | 4.84 |
| 2024-10-29 | 4.72 |
| 2024-10-28 | 4.65 |
| 2024-10-25 | 4.74 |
| 2024-10-24 | 4.77 |
| 2024-10-23 | 4.90 |
| 2024-10-22 | 4.92 |
| 2024-10-21 | 4.90 |
| 2024-10-18 | 4.65 |
| 2024-10-17 | 4.24 |
| 2024-10-16 | 4.27 |
| 2024-10-15 | 4.04 |
| 2024-10-14 | 4.20 |
| 2024-10-11 | 4.34 |
| 2024-10-10 | 4.32 |
| 2024-10-09 | 4.42 |
| 2024-10-08 | 4.31 |
| 2024-10-07 | 4.13 |
| 2024-10-04 | 4.12 |
| 2024-10-03 | 4.10 |
| 2024-10-02 | 4.00 |